Autor: "Hepford SA" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: A Receptor Story: Insulin Resistance Pathophysiology and Physiologic Insulin Resensitization's Role as a Treatment Modality.
Autorzy:: Lewis ST; Eselle Health, La Jolla, CA 92037, USA.
Greenway F; Clinical Trials Unit, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA 77808, USA.
Tucker TR; Department of Developmental and Cell Biology, University of California Irvine, Irvine, CA 92617, USA.
Alexander M; Department of Surgery, University of California Irvine, Orange, CA 92686, USA.
Jackson LK; Well Cell Global, Medical and Scientific Advisory Board, Houston, TX 77079, USA.
Hepford SA; Well Cell Global, Medical and Scientific Advisory Board, Houston, TX 77079, USA.
Loveridge B; Well Cell Global, Medical and Scientific Advisory Board, Houston, TX 77079, USA.
Lakey JRT; Department of Surgery, University of California Irvine, Orange, CA 92686, USA.; Department of Biomedical Engineering, University of California Irvine, Irvine, CA 92868, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jun 30; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 30.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Insulin Resistance*
Diabetes Mellitus, Type 2*/metabolism
Humans ; Insulin/metabolism ; Ligands ; Insulin, Regular, Human ; Blood Glucose/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Physiologic Insulin Resensitization as a Treatment Modality for Insulin Resistance Pathophysiology.
Autorzy:: Greenway F; Clinical Trials Unit, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA 70808, USA.
Loveridge B; Diabetes Relief, Layton, UT 84041, USA.
Grimes RM; Department of Internal Medicine, McGovern Medical School, University of Texas Health Science Center, Houston, TX 77030, USA.
Tucker TR; Department of Development and Cell Biology, University of California Irvine, Irvine, CA 92617, USA.
Alexander M; Department of Surgery, University of California Irvine, Orange, CA 92868, USA.
Hepford SA; Well Cell Global LLC, Houston, TX 77079, USA.
Fontenot J; Lafayette Arthritis and Endocrine Clinic, Lafayette, LA 70506, USA.
Nobles-James C; Division of Endocrinology, Mercer University School of Medicine, Macon, GA 31207, USA.
Wilson C; Well Cell Support LLC, Houston, TX 77079, USA.
Starr AM; Department of Orthopedic Surgery, Asheville Orthopedic Associates P.A, Asheville, NC 28801, USA.
Abdelsaid M; Biomedical Sciences Department, Mercer University School of Medicine, Savannah, GA 31404, USA.
Lewis ST; Eselle Health, Inc., La Jolla, CA 92037, USA.
Lakey JRT; Department of Surgery, University of California Irvine, Orange, CA 92868, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2022 Feb 08; Vol. 23 (3). Date of Electronic Publication: 2022 Feb 08.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Insulin Resistance*
Diabetes Mellitus, Type 2/*drug therapy
Insulin, Regular, Human/*therapeutic use
Diabetes Mellitus, Type 2/metabolism ; Glycated Hemoglobin/metabolism ; Humans ; Insulin Secretion/drug effects ; Insulin, Regular, Human/pharmacology ; Pancreas/drug effects ; Pancreas/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Hepford SA"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Język